Sakara Digital https://validator.w3.org/feed/docs/rss2.html Clean Data, Clear Path: What Data Readiness Means for AI in Life Sciences Software as a Medical Device (SaMD): Navigating FDA Classification and International Harmonization From AI Pilots to Production: Why 95% of Pharma AI Projects Fail AI-Driven Patient Recruitment and Retention: Solving Clinical Trials’ Most Persistent Challenge Decentralized Clinical Trials in 2026: The Hybrid Model Matures Site-Centric Digital Transformation: Redesigning Clinical Trial Technology Around Investigator Needs The Rise of the Electronic Trial Master File: From Digital Filing Cabinet to Compliance Intelligence Digital Twins in Clinical Trials: Virtual Patient Models Reshaping Drug Development Clinical Trial Platformization: Moving from Multi-Vendor Fragmentation to Unified Trial Technology EU Taxonomy Reporting for Pharma: Meeting Environmental Sustainability Disclosure Requirements Global Regulatory Harmonization in 2026: Aligning FDA, EMA, and PMDA for Complex Biologics FDA Digital Health Precertification: Lessons Learned and the Path Forward for Software Developers Annex 11 and Annex 22 Revisions: Preparing GxP Systems for EMA’s New AI and Data Integrity Rules FDA Computer Software Assurance (CSA): A Practical Guide to Risk-Based Validation EU Pharma Package 2026: What the New Drug Approval Framework Means for Global Pharma IT Teams The CDIO in Pharma: How the CDIO Role Is Driving AI at Scale AI-Powered Pharmacovigilance: Automating Signal Detection Validating AI Systems in GxP Environments Building AI as Scientific Infrastructure: Platform Strategies for Drug Discovery EU MDR Implementation in 2026: Technology Requirements for Medical Device Regulatory Compliance Post-Quantum Cryptography Readiness for Pharma: Preparing for the NIST PQC Transition Legacy System Integration in Life Sciences: Bridging 20-Year-Old Infrastructure with Modern Platforms SAP S/4HANA Migration for Pharma: Planning the Transition Before 2027 End of Support GxP Cloud Qualification: A Risk-Based Approach to Validating Cloud Infrastructure Zero Trust Architecture for Life Sciences: Implementing NIST SP 800-207 in GxP Environments Third-Party Risk Management for Pharma: Building Resilient Vendor Ecosystems ESG Supply Chain Auditing in Pharma: From Scope 3 Emissions to Social Compliance Serialization Exception Handling: Managing DSCSA Compliance Failures at Scale Cloud-Based Supply Chain Integration for Life Sciences: Connecting ERP, WMS, and Serialization AI-Powered Pharma Supply Chains: From Demand Sensing to Autonomous Inventory Optimization mRNA Manufacturing Technology: Digital Infrastructure for Next-Generation Vaccine and Therapeutic Production DSCSA Enforcement in 2026: Building Interoperable Drug Supply Chain Systems MES Selection for Life Sciences: A Decision Framework for Pharmaceutical Manufacturing Execution Systems Process Analytical Technology (PAT) in 2026: From Compliance Tool to Manufacturing Intelligence Platform Aseptic Manufacturing Automation: Reducing Contamination Risk Through Intelligent Systems CDMO Digital Maturity: A Strategic Framework for Contract Manufacturing Excellence Digital Twins for Pharmaceutical Manufacturing: Building Virtual Process Models That Drive Real Results Continuous Manufacturing in Pharma: The Complete Digital Transformation Guide for 2026 ATMP Manufacturing Automation: Scaling Cell and Gene Therapy Production Through Digital Innovation EU Gene Therapy Standards: Navigating EMA’s Evolving Manufacturing and Quality Requirements Chain of Identity for Cell Therapies: Digital Traceability from Patient to Product and Back Cell and Gene Therapy IT Infrastructure: Building Digital Systems for the Most Complex Therapies The Purolea Letter: What Pharma’s First AI Warning Means for GxP Compliance Wearable Device Data in Clinical Evidence: Leveraging Real-World Data for Regulatory Submissions Data Integrity and ALCOA+ in the Digital Age: Modernizing Compliance for Cloud and AI Systems Multi-Omics Data Integration: Technology Architecture for Precision Medicine and Biomarker Discovery Real-World Evidence Strategy: Building RWE Capabilities for Regulatory and Commercial Decision-Making Master Data Management for Life Sciences: Creating a Single Source of Truth Across Global Operations Data Lakehouse Architecture for Pharma: Unifying Clinical, Manufacturing, and Commercial Data FAIR Data Principles for Life Sciences: Building Findable, Accessible, Interoperable, and Reusable Data Assets